Lobbying Relationship

Client

Viatris Inc.

More records

Lobbying firm

FEROX STRATEGIES

More records

  • Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.

Duration: to

General Issues: Pharmacy, Copyright/Patent/Trademark, Trade (Domestic & Foreign), Health Issues

Spending: about $1,180,000 (But it's complicated. Here's why.)

Agencies lobbied since 2018: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)

Related Foreign Entities: Mylan N.V. (Hertfordshire, EN6 1AG, GBR); contribution to lobbying: $0; ownership 100%; Mylan Holdings Ltd. (Hertfordshire EN6 1AG, GBR); contribution to lobbying: $0; ownership 100%

Bills mentioned

H.R.2212: CREATES Act of 2017

Sponsor: Tom Marino (R-Pa.)

S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.7251: Hatch-Waxman Integrity Act of 2018

Sponsor: Bill Flores (R-Texas)

S.3738: Hatch-Waxman Integrity Act of 2018

Sponsor: Orrin G. Hatch (R-Utah)

H.R.6294: REVAMP Act

Sponsor: John Shimkus (R-Ill.)

H.R.965: CREATES Act of 2019

Sponsor: David Cicilline (D-R.I.)

S.340: CREATES Act of 2019

Sponsor: Patrick J. Leahy (D-Vt.)

S.474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive...

Sponsor: Ron Wyden (D-Ore.)

H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019

Sponsor: Bobby L. Rush (D-Ill.)

H.R.938: BLOCKING Act of 2019

Sponsor: Kurt Schrader (D-Ore.)

H.R.1520: Further Extension of Continuing Appropriations Act, 2021

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.1503: Orange Book Transparency Act of 2020

Sponsor: Robin Kelly (D-Ill.)

H.R.2064: To amend title XI of the Social Security Act to require manufacturers of...

Sponsor: Judy Chu (D-Calif.)

S.64: Preserve Access to Affordable Generics and Biosimilars Act

Sponsor: Amy Klobuchar (D-Minn.)

H.R.987: Strengthening Health Care and Lowering Prescription Drug Costs Act

Sponsor: Lisa Blunt Rochester (D-Del.)

H.R.2375: Preserve Access to Affordable Generics and Biosimilars Act

Sponsor: Jerrold Nadler (D-N.Y.)

H.R.2374: Stop STALLING Act

Sponsor: Hakeem Jeffries (D-N.Y.)

S.1224: Stop STALLING Act

Sponsor: Amy Klobuchar (D-Minn.)

S.1895: Lower Health Care Costs Act

Sponsor: Lamar Alexander (R-Tenn.)

S.2103: Affordable Insulin Approvals Now Act

Sponsor: Richard J. Durbin (D-Ill.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

S.1416: Affordable Prescriptions for Patients Act of 2019

Sponsor: John Cornyn (R-Texas)

H.R.1865: Further Consolidated Appropriations Act, 2020

Sponsor: Bill Pascrell Jr. (D-N.J.)

H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors...

Sponsor: David McKinley (R-W.Va.)

S.3538: Strengthening America’s Supply Chain and National Security Act

Sponsor: Marco Rubio (R-Fla.)

H.R.6201: Families First Coronavirus Response Act

Sponsor: Nita M. Lowey (D-N.Y.)

H.R.748: CARES Act

Sponsor: Joe Courtney (D-Conn.)

H.R.6179: Increasing Access to Biosimilars Act of 2020

Sponsor: Tony Cárdenas (D-Calif.)

S.4134: Increasing Access to Biosimilars Act of 2020

Sponsor: John Cornyn (R-Texas)

H.R.6395: William M. (Mac) Thornberry National Defense Authorization Act for...

Sponsor: Adam Smith (D-Wash.)

S.4049: National Defense Authorization Act for Fiscal Year 2021

Sponsor: James M. Inhofe (R-Okla.)

H.R.133: Consolidated Appropriations Act, 2021

Sponsor: Henry Cuellar (D-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Cristina Antelo Legal Fellow, Senate Democratic Steering Committee
Lucia Alonzo Leg. Correspondent/Policy Aide, Sen. Claire McCaskill
Mark Williams Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson
Debra Dixon Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of Justice.
Michael Taggart Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page